第一作者:
Joakim,Bergman
第一单位:
Department of Pharmacology and Clinical Neuroscience (J.B., A.D., J.G., T.B., A.S.), Umeå University; Institute of Neuroscience and Physiology (H.Z., K.B.), Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, Queen Square, London, UK; UmanDiagnostics AB (N.N.), Umeå; and Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Danderyd Hospital AB, Stockholm, Sweden.
作者:
DOI
10.1212/NXI.0000000000000271
PMID
27536708
发布时间
2022-03-10
- 浏览2
Neurology(R) neuroimmunology & neuroinflammation
2016年3卷5期
e271页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



